Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Antimicrobial Agents and Chemotherapy|August 10, 2016
Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia ComplexDouglas Fraser-Pitt, Derry Mercer, Emma Lovie, et al.
Antimicrobial Agents and Chemotherapy|May 25, 2021
Preliminary Characterization of NP339, a Novel Polyarginine Peptide with Broad Antifungal ActivityVanessa Duncan, Daniel Smith, Laura Simpson, et al.
Frontiers in Cellular and Infection Microbiology|August 1, 2020
Antimicrobial Susceptibility Testing of Antimicrobial Peptides to Better Predict EfficacyDerry K Mercer, Marcelo D T Torres, Searle S Duay, et al.
ACS Infectious Diseases|June 10, 2021
Antimicrobial Susceptibility Testing of Antimicrobial Peptides Requires New and Standardized Testing StructuresMarita Meurer, Deborah A O'Neil, Emma Lovie, et al.
Infection and Immunity|March 28, 2018
Cysteamine, an Endogenous Aminothiol, and Cystamine, the Disulfide Product of Oxidation, Increase Pseudomonas aeruginosa Sensitivity to Reactive Oxygen and Nitrogen Species and Potentiate Therapeutic Antibiotics against Bacterial InfectionDouglas J Fraser-Pitt, Derry K Mercer, Daniel Smith, et al.
Plos One|December 28, 2020
Oral cysteamine as an adjunct treatment in cystic fibrosis pulmonary exacerbations: An exploratory randomized clinical trialGraham Devereux, Danielle Wrolstad, Stephen J Bourke, et al.
Pageof 1